Summit Securities Group
GSK icon

Summit Securities Group’s GSK GSK Stock Holding History

Summit Securities Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,280
Closed -$70K – 1023
2022
Q2 		$70K Buy
1,280
+320
+33% +$17.7K 0.01% 471
2022
Q1 		$52K Buy
+960
New +$52.1K 0.01% 601
2021
Q2 		– Sell
-56
Closed -$250K – 758
2021
Q1 		$250K Sell
56
-142
-72% -$6.44K 0.03% 482
2020
Q4 		$913K Buy
198
+20
+11% +$919 0.08% 245
2020
Q3 		$836K Buy
178
+83
+87% +$4.16K 0.09% 171
2020
Q2 		$485K Buy
95
+15
+19% +$770 0.06% 238
2020
Q1 		$379K Sell
80
-174
-69% -$9.28K 0.07% 181
2019
Q4 		$1.49M Buy
254
+191
+303% +$10.6K 0.11% 171
2019
Q3 		$337K Hold
63
– – 0.03% 242
2019
Q2 		$316K Buy
+63
New +$3.16K 0.04% 252
2015
Q1 		– Sell
-48
Closed -$10K – 490
2014
Q4 		$10K Sell
48
-14
-23% -$783 ﹤0.01% 449
2014
Q3 		$7K Buy
+62
New +$3.8K ﹤0.01% 556
2013
Q3 		– Sell
-217
Closed -$13K – 472
2013
Q2 		$13K Buy
+217
New +$13.8K 0.01% 286

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Summit Securities Group's GSK Position: Q3 2026 in Review

Summit Securities Group sold out of GSK (GSK) in Q3 2026, closing a stake of 100 shares — an estimated $5.24K sold.

Summit Securities Group first reported a position in GSK in Q2 2013 and held it in 37 quarters. The position peaked at $1.97M in Q4 2019. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Summit Securities Group reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Summit Securities Group sold 100 GSK shares in Q3 2026, an estimated $5.24K.
  • Summit Securities Group first reported a position in GSK in Q2 2013 and held it in 37 quarters.
  • Summit Securities Group's GSK position peaked at $1.97M in Q4 2019.
  • 654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.